Last reviewed · How we verify

NCT03871192

Injections in the Diagnosis and Treatment of Lumbar Facet Syndrome

Status unknown NA Last updated 15 March 2019
What this trial tests

NA trial testing FACET JOINT UNDER CT GUIDANCE in Facet Joint Pain in 100 participants. Status unknown.

Timeline
15 August 2018
Primary endpoint
15 August 2019
15 August 2020

Quick facts

Lead sponsorComplejo Hospitalario Universitario de Granada
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment100
Start date15 August 2018
Primary completion15 August 2019
Estimated completion15 August 2020
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Complejo Hospitalario Universitario de Granada

Who can join

Adults 18 to 79, any sex, with Facet Joint Pain or Facet Syndrome of Lumbar Spine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In suspected facet joints pain, it is recommended to perform nerve blocks to establish the diagnosis with positive results being and indicator of successful of most permanent treatment of facet pain by rhizolysis. Nevertheless, the usefulness of intraarticular joint injection for diagnosis and prediction of successful neurolysis have been scarcely studied. The main purpose of this trial is to compare both methods, nerve block and intra articular injection, in diagnosis and treatment of facet joints pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Facet Joint Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03871192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing